Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MPO | P05164 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.56 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.56 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | XIAP | P98170 | 1/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL660499 | 1.00 | CTNNB1 (0.59) | CTNNB1MAPTKDM4EMEN1LMNA | |
| SCHEMBL1025267 | 1.00 | CTNNB1 (0.59) | CTNNB1MAPTKDM4EMEN1LMNA | |
| SCHEMBL29397866 | 1.00 | CTNNB1 (0.59) | CTNNB1MAPTKDM4EMEN1LMNA | |
| SCHEMBL29397858 | 1.00 | CTNNB1 (0.59) | CTNNB1MAPTKDM4EMEN1LMNA | |
| SCHEMBL29482763 | 1.00 | CTNNB1 (0.59) | CTNNB1MAPTKDM4EMEN1LMNA | |
| SCHEMBL93516 | 1.00 | CTNNB1 (0.59) | CTNNB1MAPTKDM4EMEN1LMNA | |
| Hydrochloric Acid SCHEMBL29400669 | 0.98 | CTNNB1 (0.58) | CTNNB1MAPTKDM4EMEN1LMNA | |
| Hydrochloric Acid SCHEMBL5967395 | 0.98 | CTNNB1 (0.58) | CTNNB1MAPTKDM4EMEN1LMNA | |
| Hydrochloric Acid SCHEMBL29370597 | 0.98 | CTNNB1 (0.58) | CTNNB1MAPTKDM4EMEN1LMNA | |
| Hydrochloric Acid SCHEMBL30030000 | 0.98 | CTNNB1 (0.58) | CTNNB1MAPTKDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4000 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260077071-A1 | Targeted Delivery of Theranostic Agents | PETER MACCALLUM CANCER INST (AU) | 2026-03-19 | — | — | US | claimed |
| EP-4709739-A1 | ANTI-BACTERIAL PEPTIDES | Agency for Science, Technology and Research (SG) | 2026-03-18 | — | — | EP | claimed |
| EP-4448020-B1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN NEUROENDOCRINE NEOPLAMS | CURASIGHT AS (DK) | 2026-02-04 | — | — | EP | claimed |
| EP-4678194-A1 | THERAPEUTIC APPLICATION OF 64CU-LABELLED CONJUGATES FOR SITE-SPECIFIC UPAR-TARGETING | Curasight A/S (DK) | 2026-01-14 | — | — | EP | claimed |
| US-12521455-B2 | Kisspeptin receptor (KISS1R) targeted therapeutics and uses thereof | RADIONETICS ONCOLOGY, INC. (US) | 2026-01-13 | — | — | US | claimed |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| WO-2025217074-A1 | KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2025-10-16 | — | — | WO | claimed |
| US-20250319215-A1 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR)-PET/CT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCCS) | CURASIGHT AS (DK) | 2025-10-16 | — | — | US | claimed |
| US-20250312499-A1 | KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. | 2025-10-09 | — | — | US | claimed |
| US-12409240-B2 | Positron emitting radionuclide labeled peptides for human uPAR PET imaging | CURASIGHT A/S (DK) | 2025-09-09 | — | — | US | claimed |
| WO-1992000995-A1 | CYCLIC CELL ADHESION MODULATION COMPOUNDS | TANABE SEIYAKU CO. LTD. (JP) | 1992-01-23 | — | — | WO | claimed |
| EP-0438519-A4 | THERAPEUTIC PEPTIDES | UNIV TULANE (US) | 1991-10-30 | — | — | EP | claimed |
| EP-0438519-A1 | THERAPEUTIC PEPTIDES | The Administrators of The Tulane Educational Fund (US) | 1991-07-31 | — | — | EP | claimed |
| EP-0410541-A1 | Fibrinogen receptor antagonists | MERCK & CO. INC. (US) | 1991-01-30 | — | — | EP | claimed |
| EP-0389180-A1 | Peptides and their use in therapy | BIOMEASURE, INC. (US) | 1990-09-26 | — | — | EP | claimed |
| WO-1989002897-A1 | THERAPEUTIC PEPTIDES | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1989-04-06 | — | — | WO | claimed |
| EP-0309297-A2 | Therapeutic peptides | The Administrators of The Tulane Educational Fund (US) | 1989-03-29 | — | — | EP | claimed |
| EP-0293159-A2 | Parathyroid hormone antagonists with simplified synthetic methodology | MERCK & CO. INC. (US) | 1988-11-30 | — | — | EP | claimed |
| EP-0081877-B1 | LH-RH ANTAGONISTS | COY, David Howard (US) | 1986-04-30 | — | — | EP | claimed |
| EP-0111841-A1 | LHRH preparations for intranasal administration | SYNTEX (U.S.A.) INC. (US) | 1984-06-27 | — | — | EP | claimed |